Cetuximab-Related Skin Toxicity as a Predictive Marker for Treatment Response and Prognosis in Recurrent/Metastatic Head and Neck Cancer Patients Treated with Cetuximab and Chemotherapy Combination


Çıtakkul İ., Uygun K., Bakkal Temi Y., Özden E., Kefeli U., Çabuk D., ...More

Acta Medica Nicomedia, vol.8, no.2, pp.164-168, 2025 (TRDizin) identifier